相关实验视频

Updated: Jan 20, 2026

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

炎症性肠道疾病患者肺部疾病的患病率增加:一项回顾性多中心研究

Shaina Ailawadi¹, Trishna Parikh¹, Elleson Harper²

¹Department of Internal Medicine.

Journal of clinical gastroenterology

|January 19, 2026

概括

患有炎症性肠病 (IBD) 的患者面临患各种肺部疾病 (PD) 的风险更高,包括喘和慢性支气管炎. 积极的监测和降低风险对于在IBD患者群体中管理这些风险至关重要.

科学领域:

胃肠病学胃肠病学
肺部病理学肺部病理学
流行病学流行病学

背景情况:

炎症性肠病 (IBD) 是一种复杂的疾病,其系统性影响超出了胃肠道.
肠外IBD的表现很常见,需要全面了解相关的并发症.
肺部疾病 (PDs) 是IBD患者的重要,但经常被忽视的并发症.

研究的目的:

研究炎症性肠病 (IBD) 与随后发展的肺部疾病 (PDs) 之间的关联.
量化与对照人群相比,在被诊断患有IBD的患者中增加特定肺部疾病的风险.
为临床实践提供有关IBD患者肺部健康监测的信息.

主要方法:

使用TrinetX数据库进行回顾性队列研究.
确定服用特定药物的IBD患者和没有IBD的匹配对照组.
使用倾向性得分匹配 (PSM) 来确保队列可比性.
对发展各种肺部疾病和全因死亡率的几率比率 (OR) 的分析.

主要成果:

与对照组相比,IBD队列 (n=155,668) 显示大多数评估的肺部疾病的患病率明显增加.
观察到喘 (OR: 2.17),支气管切除 (OR: 2.35),慢性支气管炎 (OR: 2.40) 和血管炎 (OR: 2.33) 的风险明显更高.
在IBD组中观察到脏病和肺胸部发病率降低.

结论:

患有IBD的患者患上一系列肺部疾病的风险显著增加.
这些发现强调了提高对IBD患者肺部并发症的警的重要性.
临床医生应在IBD患者的肺部健康方面实施主动监测和降低风险的策略.

关键词:

肠 - 肺轴 - 肠 - 肺轴炎症性肠病是一种炎症性肠病.肺部疾病肺部疾病

更多相关视频

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Published on: September 1, 2017

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

相关概念视频

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Inflammatory Bowel Disease V: Surgical Management

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Murine studies in models of colonic inflammation have demonstrated that a small percentage (1 - 5%) of mesenchymal stem cells (MSC) injected intravenously or intraperitoneally home to the inflamed colon1,2. This study shows that ultrasound-guided intracardiac injections of MSCs result in increased localization to the...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Dynamic adhesion of immune cells to the vessel wall is a prerequisite for gut homing. Here, we present a protocol for a functional in vitro assay for the impact analysis of anti-integrin antibodies, chemokines or other factors on the dynamic cell adhesion of human cells using addressin-coated...